September 05, 2024
Thursday September 5, 2024 – 4.30pm – Auditoire Maisin
Perrine EVRARD – Clinical Pharmacy and Pharmacoepidemiology research group (CLIP)
Enhancing the uptake of benzodiazepine deprescribing in nursing homes: Insights from behaviour-change theories and implementation science
Promotor: Prof Anne Spinewine
Co-promotor: Prof Séverine Henrard
Related publications:
- Evrard P, Henrard S, Foulon V, Spinewine A. Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study. J Am Geriatr Soc. 2020;68(12):2768-2777.
- Evrard P, Pétein C, Beuscart JB, Spinewine A. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework. Implement Sci. 2022;17(1):41.
- Evrard P, Damiaens A, Patey AM, Grimshaw JM, Spinewine A. Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups. Explor Res Clin Soc Pharm. 2023;9:100258.
- Evrard P, Henrard S, Spinewine A. Development of a Behavior-Change Intervention toward Benzodiazepine Deprescribing in Older Adults Living in Nursing Homes. J Am Med Dir Assoc. 2024;25(8).
- Evrard P, Chevallereau T, Aikpitanyi J, Pétein C, Tubeuf S, Henrard S*, Spinewine A*. Feasibility of a theory-based intervention towards benzodiazepine deprescribing in Belgian nursing homes: Protocol of the END-IT NH cluster-randomized controlled trial, Under review
Info : anne.spinewine@uclouvain.be
